Lars Ekman Prothena Corp Public LTD CO (PRTA) insider trading activity

PRTA Quotes by TradingView

Lars Ekman is of PROTHENA CORP PUBLIC LTD CO. Currently has a direct ownership of 243 shares of PRTA, which is worth approximately $4,942. The most recent transaction as insider was on Jan 03, 2023, when has been sold 15,834 shares (Ordinary Shares, par value $0.01 per share) at a price of $57.4 per share, resulting in proceeds of $908,871. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243
0% 3M change
0% 12M change
Total Value Held $4,942

Lars Ekman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
SELL
Open market or private sale
$908,871 $57.4 p/Share
15,834 Reduced 98.49%
243 Ordinary Shares, par v...
Jan 03 2023
BUY
Exercise of conversion of derivative security
$101,495 $6.41 p/Share
15,834 Added 49.62%
16,077 Ordinary Shares, par v...
Dec 01 2022
SELL
Open market or private sale
$976,957 $61.7 p/Share
15,834 Reduced 98.49%
243 Ordinary Shares, par v...
Dec 01 2022
BUY
Exercise of conversion of derivative security
$101,495 $6.41 p/Share
15,834 Added 49.62%
16,077 Ordinary Shares, par v...
Nov 01 2022
SELL
Open market or private sale
$1,005,870 $63.53 p/Share
15,833 Reduced 98.49%
243 Ordinary Shares, par v...
Nov 01 2022
BUY
Exercise of conversion of derivative security
$101,489 $6.41 p/Share
15,833 Added 49.62%
16,076 Ordinary Shares, par v...
Oct 03 2022
SELL
Open market or private sale
$975,471 $61.61 p/Share
15,833 Reduced 98.49%
243 Ordinary Shares, par v...
Oct 03 2022
BUY
Exercise of conversion of derivative security
$101,490 $6.41 p/Share
15,833 Added 49.62%
16,076 Ordinary Shares, par v...
Sep 28 2022
SELL
Open market or private sale
$1,522,818 $48.09 p/Share
31,666 Reduced 99.24%
243 Ordinary Shares, par v...
Sep 28 2022
BUY
Exercise of conversion of derivative security
$202,979 $6.41 p/Share
31,666 Added 49.81%
31,909 Ordinary Shares, par v...
Nov 25 2015
SELL
Open market or private sale
$2,211,300 $73.71 p/Share
30,000 Reduced 99.2%
243 Ordinary Shares, par v...
Nov 25 2015
BUY
Exercise of conversion of derivative security
$192,300 $6.41 p/Share
30,000 Added 49.8%
30,243 Ordinary Shares, par v...

Also insider at

AMRN
AMARIN CORP PLCUK Healthcare
RARE
Ultragenyx Pharmaceutical Inc. Healthcare
Director
LE

Lars Ekman

South San Francisco, CA

Track Institutional and Insider Activities on PRTA

Follow PROTHENA CORP PUBLIC LTD CO and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRTA shares.

Notify only if

Insider Trading

Get notified when an Prothena Corp Public LTD CO insider buys or sells PRTA shares.

Notify only if

News

Receive news related to PROTHENA CORP PUBLIC LTD CO

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PRTA